on 6 April 2022, Shenzhen Zhong Ji Health Science Company Limited signed a commodity supply contract with Sinopharm Holdings Hubei Guoda Pharmacy Co,. Ltd. The signing of the Supply Contract marks the formal formation of a strategic partnership between the two parties, which is the first step of the Group's retail coverage in Mainland China after obtaining the legal rights to distribute ZJ1 VC Extended-Release Tablets, a biological product from the United States, on the Mainland. The Group's next endeavour is continuously enhancing the development and collaboration with the top 100 offline pharmaceutical retailers in China, with a view to developing a more convenient physical channel for the public.